ARCHIVES

ODAC Advice Poses Challenge to FDA: Would Iressa Approval Erode Standards?

This article is from The Cancer Letter archive.

Vol. 28 No. 41 | November 8, 2002

Download PDF Visit The Full Archive

Related Articles

Pursuit Of Truth Was Not An NIH Objective In Gallo Case, Dingell Staff Report Says

January 6, 1995

In Brief: Comprehensive Designation To MN Center; Bernardin Center Wins NCI Planning Grant

October 16, 1998

Bill Pressures HCFA To Launch Project On Reimbursement for Cancer Trials

July 26, 1996

ACS Modifies Pap Test Guidelines

November 27, 1987

In Brief: Over Half Of Ovarian Cancer Patients Staged Incorrectly; Senate Gets Funding Resolution

April 12, 1985

NIH Seeks Candidates For Research Grants Division Director

September 8, 1995